Provided by Tiger Trade Technology Pte. Ltd.

SILO PHARMA INC.

2.49
+0.05002.05%
Volume:5K
Turnover:11.66K
Market Cap:3.95M
PE:-0.49
High:2.49
Open:2.46
Low:2.46
Close:2.44
52wk High:15.15
52wk Low:2.43
Shares:1.59M
Float Shares:1.52M
Volume Ratio:0.32
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0667
EPS(LYR):-7.5654
ROE:-91.23%
ROA:-44.25%
PB:0.81
PE(LYR):-0.33

Loading ...

Sep 10, 2024

Major Issues Report

Form 8-K - Current report
Aug 30, 2024

Correspondence

Form CORRESP - Correspondence
Aug 21, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jul 27, 2024

Correspondence

Form CORRESP - Correspondence
Jul 25, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jul 08, 2024

Major Issues Report

Form 8-K - Current report
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 05, 2024

Major Issues Report

Form 8-K - Current report
Mar 25, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Jan 27, 2024

Correspondence

Form CORRESP - Correspondence
Jan 26, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]